Answers are grounded in this paper and cite their sources.
Background: Uncontrolled asthma is a significant problem in children. A subset of such children may develop allergic bronchopulmonary aspergillosis (ABPA). ABPA is often preceded by Aspergillus sensitization (AS). There is a scarcity of data on the prevalence of AS and ABPA in asthmatic children. Objectives: We undertook a systematic review and meta-analysis of the prevalence of AS and ABPA in asthmatic children, to develop an evidence-based guideline recommendation on whether children with difficult-to-control asthma should be investigated for ABPA. Methods: The authors searched PubMed and the Cochrane Library for observational studies describing the prevalence or incidence of ABPA and/or AS in asthmatic patients. We included both pediatric and adult studies being aware of the paucity of studies in children. We assessed the quality of included studies using the Newcastle–Ottawa Scale modified for cross-sectional studies. Our primary outcome measure was the prevalence of AS and ABPA in asthmatic children. Secondary outcome measures included the prevalence of AS and ABPA in adults with asthma. We conducted a meta-analysis of the prevalence of AS and ABPA, using the random-effects model. Results: We identified a total of 72 records reporting the prevalence of AS or ABPA (children = 11, adults = 44, and children and adults = 17). About two-thirds of the studies in children were of good quality. The overall pooled prevalence of AS in children was 27% (95% confidence interval [CI]: 18%, 37%), and it was significantly higher in studies including children with severe asthma (41% [95% CI: 25%, 56%]). The overall prevalence of ABPA in children was 19% (95% CI: 11%, 27%), and it was not different by asthma severity, although the number of studies was small. The overall pooled prevalence of AS and ABPA in adults was 26% (95% CI: 21%, 30%) and 11% (95% CI: 9%, 14%), respectively, with a higher prevalence of ABPA in severe asthma. Conclusion: There is a high burden of AS and ABPA in children with asthma, especially those with severe or poorly controlled asthma. We recommend screening all children with poorly controlled asthma for AS and ABPA (conditional recommendation and moderate certainty of evidence).
No takes yet. Share an insight, caveat, or question.
Mathew et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: